Navigation Links
HMS Holdings Corp. to Present at Stephens 2008 Spring Investment Conference
Date:5/29/2008

NEW YORK, May 29 /PRNewswire-FirstCall/ -- HMS Holdings Corp. (Nasdaq: HMSY) today announced that it will present at the Stephens 2008 Spring Investment Conference, which will be held June 4-5, 2008 at the New York Palace Hotel.

Walter Hosp, Chief Financial Officer of HMS Holdings Corp., will present on Thursday, June 5th at 11:30 a.m. ET.

HMS Holdings Corp. (Nasdaq: HMSY) is the nation's leader in cost management, coordination of benefits, and program integrity services for government healthcare programs. HMS serves the Medicaid programs of 40 states, 74 Medicaid managed care plans, the Centers for Medicare and Medicaid Services (CMS), and Veterans Administration facilities. HMS helps ensure that healthcare claims are paid correctly and by the responsible party. As a result of the company's services, government healthcare programs recover over $1.0 billion annually, and obtain access to data that helps them prevent billions of dollars more in erroneous payments.


'/>"/>
SOURCE HMS Holdings Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. China Pharma Holdings, Inc. Enters Into Private Placement Agreements to Raise $10 Million
2. NightHawk Radiology Holdings, Inc. to Speak at the Goldman Sachs 29th Annual Global Healthcare Conference
3. China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects
4. Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses
5. LifeCare Holdings, Inc. Announces First Quarter Results
6. NightHawk Radiology Holdings, Inc. Announces Dutch Tender Offer for Its Common Stock
7. Z Trim Holdings, Inc. Audit Report Contains Going Concern Qualification
8. InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results
9. HMS Holdings Corp. to Present at Bank of America 2008 Healthcare Conference
10. Zimmer Holdings to Present at Deutsche Bank 33rd Annual Health Care Conference
11. XELR8 Holdings Announces Record First Quarter Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... DrugDev ... announcement that it is one of the early adopters completing EU-U.S. Privacy Shield Certification ... designed to provide companies on both sides of the Atlantic with a mechanism to ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... celebrating the passage of the most comprehensive mental health systems reform legislation in ... support of the President, and the commitment of our elected officials to improving ...
(Date:12/7/2016)... York, NY (PRWEB) , ... December 07, 2016 ... ... amounts of the drug in their bodies, a researcher at the Icahn School ... journal Pediatric Research. , The study found that when young children are exposed ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... of Smart Device Remote Control through a new partnership with Splashtop Inc. This ... strengthens its mobile solutions to help businesses maximize their uptime and productivity. , ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has announced ... report to their offering. ... , The report provides separate comprehensive ... , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: